{{NoteTA
|zh-cn:烟;zh-tw:菸
}}

{{Expand Japanese|ニコチンアミドモノヌクレオチド|date=2021}}
{{Chembox
<!-- Images -->
| ImageFile = Nicotinamide mononucleotide.svg
| ImageSize = 200px
| ImageAlt =
<!-- Names -->
| IUPACName = 3-Carbamoyl-1-[5-''O''-(hydroxyphosphinato)-β-<small>D</small>-ribofuranosyl]pyridinium
| OtherNames = {{unbulleted list | Nicotinamide ribonucleoside 5'-phosphate | Nicotinamide <small>D</small>-ribonucleotide | β-Nicotinamide ribose monophosphate| Nicotinamide nucleotide }}
<!-- Sections -->
| Section1 = {{Chembox Identifiers
| CASNo =  1094-61-7 
| CASNo_Ref = {{cascite|correct|CAS}}
| Beilstein = 3570187
| ChEBI = 16171
| ChEMBL = 610238
| EINECS = 214-136-5
| KEGG = C00455
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2KG6QX4W0V
| PubChem = 16219737
| ChemSpiderID = 13553
| SMILES = c1cc(c[n+](c1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)[O-])O)O)C(=O)N
| StdInChI = 1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/t7-,8-,9-,11-/m1/s1
| StdInChIKey = DAYLJWODMCOQEW-TURQNECASA-N
  }}
| Section2 = {{Chembox Properties
| C=11|H=15|N=2|O=8|P=1
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = 
  }}
| Section3 = {{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
  }}
}}
烟酰胺单核苷酸（{{lang-en|Nicotinamide Mononucleotide}}，缩写“NMN”或“β-NMN”）是一种由[[核糖|核糖]]和[[烟酰胺|烟酰胺]]衍生的[[核苷酸|核苷酸]]。<ref name=Bogan2008/>与[[烟酰胺核糖苷|烟酰胺核糖苷]]一样，NMN是[[烟酸|烟酸]]的衍生物，人类也有利用NMN生成[[烟酰胺腺嘌呤二核苷酸|烟酰胺腺嘌呤二核苷酸]](NADH)的酶<ref name=Bogan2008>{{cite journal | vauthors = Bogan KL, Brenner C | title = Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition | journal = Annual Review of Nutrition | volume = 28 | pages = 115–30 | date = 2008 | pmid = 18429699 | doi = 10.1146/annurev.nutr.28.061807.155443 }}</ref>。在小鼠中，NMN在10分钟内通过小肠进入细胞，通过Slc12a8 NMN转运体转化为NAD+。<ref>{{Cite journal|date=January 2019|title=Slc12a8 is a nicotinamide mononucleotide transporter|url=https://www.nature.com/articles/s42255-018-0009-4|journal=Nature|access-date=2021-01-05|archive-date=2022-01-07|archive-url=https://web.archive.org/web/20220107073110/https://www.nature.com/articles/s42255-018-0009-4|dead-url=no}}</ref>

因为NADH是[[线粒体|线粒体]]内过程、[[去乙醯酶|去乙醯酶]]和PARP的[[辅因子|辅因子]]，NMN已经在动物模型中作为潜在的神经保护和抗衰老剂而被研究<ref>{{cite journal | vauthors = Brazill JM, Li C, Zhu Y, Zhai RG | title = + synthase… It's a chaperone… It's a neuroprotector | journal = Current Opinion in Genetics & Development | volume = 44 | pages = 156–162 | date = June 2017 | pmid = 28445802 | pmc = 5515290 | doi = 10.1016/j.gde.2017.03.014 }}</ref><ref>{{cite journal|title=Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice|journal=Cell Metabolism|date=13 December 2016|url=https://www.cell.com/cell-metabolism/fulltext/S1550-4131(16)30495-8|access-date=2021-01-05|archive-date=2020-09-09|archive-url=https://web.archive.org/web/20200909185433/https://www.cell.com/cell-metabolism/fulltext/S1550-4131(16)30495-8|dead-url=no}}</ref>。膳食补充剂公司积极推销NMN产品，宣传这些好处。<ref>{{cite news|vauthors=Stipp D|title=Beyond Resveratrol: The Anti-Aging NAD Fad|url=https://blogs.scientificamerican.com/guest-blog/beyond-resveratrol-the-anti-aging-nad-fad|work=[[Scientific_American|Scientific American]] Blog Network|date=March 11, 2015|language=en|accessdate=2021-01-05|archive-date=2021-01-26|archive-url=https://web.archive.org/web/20210126100713/https://blogs.scientificamerican.com/guest-blog/beyond-resveratrol-the-anti-aging-nad-fad/|dead-url=no}}</ref>日本东京新宿庆应义塾大学医学院最近的一项人体研究表明，不超過500毫克的NMN剂量对男性是安全的。<ref>{{Cite journal |last=Irie |first=Junichiro |last2=Inagaki |first2=Emi |last3=Fujita |first3=Masataka |last4=Nakaya |first4=Hideaki |last5=Mitsuishi |first5=Masanori |last6=Yamaguchi |first6=Shintaro |last7=Yamashita |first7=Kazuya |last8=Shigaki |first8=Shuhei |last9=Ono |first9=Takashi |last10=Yukioka |first10=Hideo |last11=Okano |first11=Hideyuki |date=2020 |title=Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men |url=https://www.jstage.jst.go.jp/article/endocrj/67/2/67_EJ19-0313/_article |journal=Endocrine Journal |language=en |volume=67 |issue=2 |pages=153–160 |doi=10.1507/endocrj.EJ19-0313 |issn=0918-8959 |access-date=2021-01-05 |archive-date=2021-04-06 |archive-url=https://web.archive.org/web/20210406214034/https://www.jstage.jst.go.jp/article/endocrj/67/2/67_EJ19-0313/_article |dead-url=no }}</ref>

烟酰胺核苷(NR)激酶对NR和NMN的外源性利用至关重要。<ref name="pmid30307159">{{cite journal | vauthors = Fletcher RS, Lavery GG | title = The emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism | journal = Journal of Molecular Endocrinology | volume = 61 | issue = 3 | pages = R107-R121 | date = October 2018 | pmid = 30307159 | pmc = 6145238 | doi = 10.1530/JME-18-0085 }}</ref><ref name="pmid32595066">{{cite journal | vauthors = Cambronne XA, Kraus WL | title = + Synthesis and Functions in Mammalian Cells | journal = Trends in Biochemical Sciences | volume = 45 | issue = 10 | pages = 858–873 | date = October 2020 | pmid = 32595066 | pmc = 7502477 | doi = 10.1016/j.tibs.2020.05.010 | url = https://www.jbc.org/content/294/52/19831.long | access-date = 2021-01-05 | archive-date = 2020-10-20 | archive-url = https://web.archive.org/web/20201020195446/https://www.jbc.org/content/294/52/19831.long | dead-url = no }}</ref> 当外源性给药时，NMN必须转化为NR才能进入细胞并被重新磷酸化回NMN。NR和NMN都易受[[CD38|CD38]]环ADP核糖水解酶的胞外降解<ref name="pmid32595066" />，而CD38酶可被CD38- in -78c.等化合物抑制<ref>{{cite journal | vauthors = Tarragó MG, Chini CC, Kanamori KS, Warner GM, Caride A, de Oliveira GC, Rud M, Samani A, Hein KZ, Huang R, Jurk D, Cho DS, Boslett JJ, Miller JD, Zweier JL, Passos JF, Doles JD, Becherer DJ, Chini EN | display-authors = 6 | title = + Decline | journal = Cell Metabolism | volume = 27 | issue = 5 | pages = 1081–1095.e10 | date = May 2018 | pmid = 29719225 | pmc = 5935140 | doi = 10.1016/j.cmet.2018.03.016 }}</ref>。

==参考文献==
{{reflist}}

[[Category:核苷酸|Category:核苷酸]]